A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus produces hospital- and community-acquired infections, with methicillin-resistant S. aureus posing a serious public health threat. The golden carotenoid pigment of S. aureus , staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil-based killing, and early enzymatic steps in staphyloxanthin production resemble those for cholesterol biosynthesis. We determined the crystal structures of S. aureus dehydrosqualene synthase (CrtM) at 1.58 angstrom resolution, finding structural similarity to human squalene synthase (SQS). We screened nine SQS inhibitors and determined the structures of three, bound to CrtM. One, previously tested for cholesterol-lowering activity in humans, blocked staphyloxanthin biosynthesis in vitro (median inhibitory concentration ∼100 nM), resulting in colorless bacteria with increased susceptibility to killing by human blood and to innate immune clearance in a mouse infection model. This finding represents proof of principle for a virulence factor–based therapy against S. aureus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To combat ROS, S. aureus uses a number of defensive molecules, including catalase (KatA), superoxide dismutases (SodA/M), and the golden pigment staphyloxanthin (36–44).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is important because the generation of reactive oxygen species (ROS) such as O2− and H2O2 by neutrophils is a crucial host defense mechanism against S. aureus (36, 37).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V., Hoffman, H. M., Bastian, J. F., Fierer, J., & Nizet, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050846 · Cited by 752
Self-citationClauditz, A., Resch, A., Wieland, K.-P., Peschel, A., & Götz, F. (2006) · Infection and Immunity · doi:10.1128/iai.00204-06 · Cited by 509
Lyon, G. J., Mayville, P., Muir, T. W., & Novick, R. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13330 · Cited by 263
Crystal Structure of Human Squalene Synthase
Pandit, J., Danley, D. E., Schulte, G. K., Mazzalupo, S., Pauly, T. A., Hayward, C. M., Hamanaka, E. S., Thompson, J. F., & Harwood, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004132200 · Cited by 238
Bisphosphonates target multiple sites in both cis - and trans -prenyltransferases
Guo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702254104 · Cited by 184
Self-citationBacterial virulence as a target for antimicrobial chemotherapy
Alksne, L. E., & Projan, S. J. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00155-5 · Cited by 158
Antimicrobial Resistance: It's Not Just for Hospitals
Bancroft, E. A. (2007) · JAMA · doi:10.1001/jama.298.15.1803 · Cited by 141
Anchor Structure of Staphylococcal Surface Proteins
Ton-That, H., & Schneewind, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24316 · Cited by 140
Research works printed but not linked: 1
- National Research Council. Treating Infectious Diseases in a Microbial World: Report of Two Workshops on Novel Antimicrobial Therapeutics. National Academies Press; Washington, DC: 2006. pp. 21–22. [PubMed] [Google Scholar]
Cited by
Items 101–200 of 505
Structural study of TcaR and its complexes with multiple antibiotics from Staphylococcus epidermidis
Chang, Y.-M., Jeng, W.-Y., Ko, T.-P., Yeh, Y.-J., Chen, C. K.-M., & Wang, A. H.-J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913302107 · Cited by 89
Self-citationC/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice
Kyme, P., Thoennissen, N. H., Tseng, C. W., Thoennissen, G. B., Wolf, A. J., Shimada, K., Krug, U. O., Lee, K., Müller-Tidow, C., Berdel, W. E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62070 · Cited by 86
Self-citationLiang, P. (2009) · Biochemistry · doi:10.1021/bi900371p · Cited by 83
Rashid, R., Cazenave‐Gassiot, A., Gao, I. H., Nair, Z. J., Kumar, J. K., Gao, L., Kline, K. A., & Wenk, M. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175886 · Cited by 81
Beyond killing: Can we find new ways to manage infection?
Vale, P. F., McNally, L., Doeschl‐Wilson, A., King, K. C., Popat, R., Domingo-Sananes, M. R., Allen, J. E., Soares, M. P., & Kümmerli, R. (2016) · Evolution Medicine and Public Health · doi:10.1093/emph/eow012 · Cited by 97
“without interfering with commensal conspecifics [17].”
Herring Oil and Omega Fatty Acids Inhibit Staphylococcus aureus Biofilm Formation and Virulence
Kim, Y.-G., Lee, J.-H., Raorane, C. J., Oh, S. T., Park, J. G., & Lee, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01241 · Cited by 78
Selvaraj, A., Valliammai, A., Muthuramalingam, P., Priya, A., Suba, M., Ramesh, M., & Pandian, S. K. (2020) · ACS Omega · doi:10.1021/acsomega.0c04252 · Cited by 92
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance
Bohlmann, L., Oliveira, D. M. P. D., El-Deeb, I. M., Brazel, E. B., Harbison-Price, N., Ong, C. Y., Rivera-Hernández, T., Ferguson, S. A., Cork, A. J., Phan, M., et al. (2018) · mBio · doi:10.1128/mbio.02391-18 · Cited by 82
Okumura, C. Y. M., & Nizet, V. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155711 · Cited by 76
Self-citationSuppression of Staphylococcus aureus virulence by a small-molecule compound
Gao, P., Ho, P., Yan, B., Sze, K. H., DAVIES, J. E., & Kao, R. Y. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720520115 · Cited by 80
“Several antivirulence attempts have focused on accessory gene regulator (agr) (9), the sortase enzyme system (10), the carotenoid biosynthetic pathway (CrtM and CrtN) (11, 12), and other regulatory pathways (MgrA and SarA) (13) or have directly targeted toxin proteins (14) and the toxins’ receptors (15).”
BackgroundStructure, catalysis, and inhibition mechanism of prenyltransferase
Chang, H., Cheng, T., & Wang, A. H. ‐. (2020) · IUBMB Life · doi:10.1002/iub.2418 · Cited by 80
“aureus, inhibiting its production could result in the production of reactive oxygen species from host neutrophils, significantly hindering bacterial growth.(17) Schwalen et al.”
BackgroundMethodSelf-citationKim, S. H., & Lee, P. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.343020 · Cited by 73
SQ109, a New Drug Lead for Chagas Disease
Veiga-Santos, P., Li, K., Lameira, L., de Carvalho, T. M. U., Huang, G., Galizzi, M., Shang, N., Li, Q., González‐Pacanowska, D., Hernández-Rodríguez, V., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03972-14 · Cited by 76
“In unrelated work, we also reported (25) that SQ109 was an inhibitor of dehydrosqualene synthase (from Staphylococcus aureus), a protein whose three-dimensional structure (26) and mechanism of action (27) are very similar to those of squalene synthase (SQS) (28), which catalyzes the first step of sterol biosynthesis i…”
BackgroundSelf-citationStaphylococcus Aureus Evasion of Innate Antimicrobial Defense
Kraus, D., & Peschel, A. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.437 · Cited by 96
Lee, J., Park, J.-H., Cho, M. H., & Lee, J. (2012) · Current Microbiology · doi:10.1007/s00284-012-0229-x · Cited by 75
Anti-Infectious Agents against MRSA
Koyama, N., Inokoshi, J., & Tomoda, H. (2012) · Molecules · doi:10.3390/molecules18010204 · Cited by 88
“Oldfield and coworkers extensively studied the biological activity of BPH-652 [50].”
BackgroundInfluentialValliammai, A., Selvaraj, A., Muthuramalingam, P., Priya, A., Ramesh, M., & Pandian, S. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111933 · Cited by 76
Kotaiah, Y., Kerru, N., Harikrishna, N., Rao, C. V., Yamini, L., & Vijjulatha, M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.006 · Cited by 74
Pérez-Fons, L., Steiger, S., Khaneja, R., Bramley, P. M., Cutting, S. M., Sandmann, G., & Fraser, P. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.12.009 · Cited by 74
“The diapo/apo-carotenoids from these bacterial sources have gained interest in the past years due to their ability to function as virulence factors in some pathogenic bacteria [30–32] and their potential to provide a suitable biosource of carotenoids with improved solubility and stability for the food and feed industr…”
BackgroundFree radicals and oxidative stress in bacteria
Kashmiri, Z. N., & Mankar, S. A. (2014) · Cited by 79
Squalene Synthase As a Target for Chagas Disease Therapeutics
Shang, N., Li, Q., Ko, T., Chan, H., Li, J., Zheng, Y., Huang, C.-H., Ren, F., Chen, C., Zhu, Z., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004114 · Cited by 72
“Reactions were monitored by using a continuous spectrophotometric assay for phosphate releasing enzymes [26].”
Self-citationHalimane diterpenoids: sources, structures, nomenclature and biological activities
Roncero, A. M., Tobal, I. E., Moro, R. F., David Diez, A., & Marcos, I. S. (2018) · Natural Product Reports · doi:10.1039/c8np00016f · Cited by 71
Wang, Z., Zhu, J., Li, W., Li, R., Wang, X., Qiao, H., Sun, Q., & Zhang, H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.269 · Cited by 70
A Biosurfactant‐Inspired Heptapeptide with Improved Specificity to Kill MRSA
Liu, Y., Ding, S., Dietrich, R., Märtlbauer, E. P., & Zhu, K. (2017) · Angewandte Chemie · doi:10.1002/ange.201609277 · Cited by 69
No, J. H., Dossin, F. D. M., Zhang, Y., Liu, Y.-L., Zhu, W., Feng, X., Yoo, J. A., Lee, E., Wang, K., Hui, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118215109 · Cited by 71
Self-citationPost, V., Wahl, P. M., Uçkay, İ., Ochsner, P. E., Zimmerli, W., Corvec, S., Loïez, C., Richards, R. G., & Moriarty, T. F. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.03.003 · Cited by 69
How Streptococcus suis serotype 2 attempts to avoid attack by host immune defenses
Xia, X., Qin, W., Zhu, H., Wang, X., Jiang, J., & Hu, J. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.03.003 · Cited by 78
Tiwari, K. B., Gatto, C., & Wilkinson, B. J. (2018) · Molecules · doi:10.3390/molecules23051201 · Cited by 68
“Thus staphyloxanthin biosynthesis has been explored as a potential drug target [16].”
BackgroundThirunavukkarasu, M., Balaji, G., Muthu, S., Raajaraman, B., & Ramesh, P. (2020) · Chemical Data Collections · doi:10.1016/j.cdc.2020.100622 · Cited by 67
Novel antimicrobial strategies to treat multi‐drug resistant Staphylococcus aureus infections
Douglas, E. J. A., Wulandari, S. W., Lovell, S. D., & Laabei, M. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14268 · Cited by 67
Engman, J., Rogstam, A., Frees, D., Ingmer, H., & von Wachenfeldt, C. (2011) · Journal of Bacteriology · doi:10.1128/jb.06414-11 · Cited by 68
“aureus against oxidative stress due to its ability to absorb excess 387 energy from reactive oxygen species and is linked to virulence (23).”
BackgroundElmesseri, R. A., Saleh, S. E., Elsherif, H. M., Yahia, I. S., & Aboshanab, K. M. (2022) · Antibiotics · doi:10.3390/antibiotics11030298 · Cited by 72
“aureus susceptible to oxidative stress of the human neutrophils in a mouse model after depigmenting the strain [16].”
BackgroundInfluentialKahlon, A. K., Roy, S., & Sharma, A. K. (2010) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2010.10507353 · Cited by 66
“Dehydrosqualene synthase (CrtM) is having structural similarity with the human squalene synthase enzyme which is involved in the cholesterol synthesis pathway in humans (Liu et al., 2008).”
BackgroundTernent, L., Dyson, R., Krachler, A. M., & Jabbari, S. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.02.011 · Cited by 81
“Some anti-virulence compounds may directly inhibit the action of bacteria on immune cells (Liu et al., 2008, for example) while others have been shown to promote host clearance of the bacteria indirectly (e.g. quorum sensing inhibitors in Hentzer et al. (2003), Rasmussen et al. (2005), Jakobsen et…”
BackgroundSong, Y., Lin, F., Yin, F., Hensler, M. E., Rodrigues, C., Mukkamala, D., Cao, R., Wang, H., Morita, C. T., González‐Pacanowska, D., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801023u · Cited by 73
Self-citationSubstituted 2-Imino-5-arylidenethiazolidin-4-one Inhibitors of Bacterial Type III Secretion
Kline, T. B., Felise, H. B., Barry, K. C., Jackson, S. R., Nguyen, H. V., & Miller, S. I. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8004515 · Cited by 62
Tong, S. Y. C., Sharma-Kuinkel, B. K., Thaden, J. T., Whitney, A. R., Yang, S.-J., Mishra, N. N., Rude, T., Lilliebridge, R. A., Selim, M. A., Ahn, S. H., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit173 · Cited by 62
“Liu et al [7] elegantly demonstrated that inhibition of staphyloxanthin production using a cholesterol biosynthesis inhibitor resulted in impaired survival of S. aureus against oxidative stress and killing in whole blood.”
BackgroundNovel agents to inhibit microbial virulence and pathogenicity
Escaich, S. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2010.511176 · Cited by 75
“A potent phosphosulfonate inhibitor (molecule 21 in Table 6) of staphyloxanthin biosynthesis was shown to decrease bacteremia in a systemic model of infection in mice [93].”
BackgroundTargeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis
Reiche, M., Warner, D. F., & Mizrahi, V. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00075 · Cited by 66
“In some ways, this strategy is analogous to targeting virulence factors (Liu et al., 2008) and assumes that the selective pressure to mutate to antibiotic resistance is not as great where the pathway is essential for pathogenesis but not survival (Clatworthy et al., 2007).”
BackgroundPhoto‐Disassembly of Membrane Microdomains Revives Conventional Antibiotics against MRSA
Hui, J., Dong, P., Liang, L., Mandal, T., Li, J., Ulloa, E. R., Zhan, Y., Jusuf, S., Zong, C., Seleem, M. N., et al. (2020) · Advanced Science · doi:10.1002/advs.201903117 · Cited by 62
“dehydrosqualene synthase (CrtM), along the pathway for STX biosynthesis (13, 14).”
BackgroundSelf-citationDehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy againstStaphylococcus aureus
Gao, P., DAVIES, J. E., & Kao, R. Y. T. (2017) · mBio · doi:10.1128/mbio.01224-17 · Cited by 58
“The first step of the pathway, dehydrosqualene synthesis, is similar to an early step in human cholesterol biosynthesis (3).”
BackgroundThe regulon of the RNA chaperone CspA and its auto-regulation in Staphylococcus aureus
Caballero, C. J., Menendez-Gil, P., Catalan‐Moreno, A., Vergara-Irigaray, M., García, B., Segura, V., Irurzun, N., Villanueva, M., Mozos, I. R. D. L., Solano, C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1284 · Cited by 60
“Hydrogen peroxidase (H2O2) assay was performed as previously described with slight modifications (44).”
MethodTotsika, M. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0227 · Cited by 64
Challenges and New Therapeutic Approaches in the Management of Chronic Wounds
Sun, H., Pulakat, L., & Anderson, D. W. (2020) · Current Drug Targets · doi:10.2174/1389450121666200623131200 · Cited by 63
Carotenoid production in Bacillus subtilis achieved by metabolic engineering
Yoshida, K., Ueda, S., & Maeda, I. (2009) · Biotechnology Letters · doi:10.1007/s10529-009-0082-6 · Cited by 55
“It has been shown that staphyloxanthin promotes resistance of S. aureus to reactive oxygen species and host neutrophil-based killing, and CrtM in the staphyloxanthin synthetic pathway could be a target site for a virulence factor-based therapy against S. aureus ( Liu et al. 2008 ).”
BackgroundWang, Y., Chen, F., Di, H., Xu, Y., Xiao, Q., Wang, X., Wei, H., Lu, Y., Zhang, L., Zhu, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01984 · Cited by 53
Alavi, M., Antonic, V., Stojadinovic, A., Zhang, B., & Mina Izadjoo, M. (2013) · Infection and Drug Resistance · doi:10.2147/idr.s49039 · Cited by 27
Nobre, L. S., Todorović, S., Tavares, A. F. N., Oldfield, E., Hildebrandt, P., Teixeira, M. S., & Saraiva, L. M. (2010) · Journal of Bacteriology · doi:10.1128/jb.01378-09 · Cited by 53
“Inhibition of carotenoid biosynthesis (13) results in bacteria that are white (since they lack the carotenoid pigment) and are thus cleared by host defenses.”
BackgroundSelf-citationThe global need for effective antibiotics—A summary of plenary presentations
Alván, G., Edlund, C., & Heddini, A. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.007 · Cited by 62
Ragi, K., Kakkassery, J. T., Raphael, V. P., Johnson, R., & Vidhya Thomas, K. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00225-3 · Cited by 78
Raft-Like Membrane Domains in Pathogenic Microorganisms
(2015) · Current Topics in Membranes · doi:10.1016/bs.ctm.2015.03.005 · Cited by 51
Staphylococcus aureus , Antibiotic Resistance, and the Interaction with Human Neutrophils
Rungelrath, V., & DeLeo, F. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8127 · Cited by 68
“S. aureus possesses multiple factors to protect itself from ROS and reactive nitrogen radicals, including genes encoding superoxide dismutases (SodA and SodM), catalase (KatA), alkyl hydroperoxide reductase (AhpCF), staphylococcal peroxidase inhibitor (SPIN), flavohaemoglobin (Hmp), and staphyloxanthin.”
BackgroundInfluentialOrozco, M. F. S., Lorenzo‐Leal, A. C., DeAlba-Montero, I., Marín, N. P., Santana, M. Á. C., & Bach, H. (2023) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2023.102715 · Cited by 54
Olivier, A., Lemaire, S., Françoise Van Bambeke, A., Tulkens, P. M., & Oldfield, E. (2009) · The Journal of Infectious Diseases · doi:10.1086/606012 · Cited by 52
“B, Intracellular growth of SH1000 and 8325-4 in human umbilical vein endothelial cells (HUVECs), and of SH1000, SA63062, SA63049, SA63063, USA300 (4 clinical isolates) and 8325-4 in THP-1 macrophages in the absence (control; strains are ranked according to the intensity of their pigmentation as assessed by visual insp…”
InfluentialSelf-citationGenetic and Virulent Difference Between Pigmented and Non-pigmented Staphylococcus aureus
Zhang, J., Suo, Y., Zhang, D., Jin, F., Zhao, H., & Shi, C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00598 · Cited by 48
“…stress and neutrophil killing (Liu et al., 2005), and the inhibition of STX synthesis has been demonstrated to attenuate the virulence of S. aureus (Liu et al., 2008), we hypothesize that the non-pigmented S. aureus strains would have attenuated virulence compared to pigmented ones because of the…”
BackgroundInfluentialRubini, D., Banu, S. F., Hari, B. N. V., Devi, D. R., Gowrishankar, S., Pandian, S. K., & Nithyanand, P. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.06.017 · Cited by 50
Vila, T., Kong, E. F., Ibrahim, A., Piepenbrink, K., Shetty, A. C., McCracken, C., Bruno, V., & Jabra-Rizk, M. A. (2019) · Virulence · doi:10.1080/21505594.2019.1635418 · Cited by 50
“inhibitor farnesyl thiopyrophosphate (FPS) (PDB ID: 3W7F) [26] (Figure 7(a)).”
Feng, X., Hu, Y., Zheng, Y., Zhu, W., Li, K., Huang, C., Ko, T., Ren, F., Chan, H.-C., Nega, M., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.018 · Cited by 54
Self-citationSethupathy, S., Vigneshwari, L., Valliammai, A., Balamurugan, K., & Pandian, S. K. (2017) · RSC Advances · doi:10.1039/c7ra02934a · Cited by 51
The role of the innate immune system on pulmonary infections
Galeas‐Pena, M., McLaughlin, N., & Pociask, D. A. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0304 · Cited by 53
Staphylococcus aureus versus neutrophil: Scrutiny of ancient combat
Nasser, A., Moradi, M., Jazireian, P., Safari, H., Sani, M. A., Pourmand, M. R., & Azimi, T. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.04.026 · Cited by 54
Quintero-Quiroz, C., Botero, L. E., Zárate-Triviño, D. G., Acevedo-Yepes, N., Escobar, J. S., Pérez, V. Z., & Riaño, L. J. C. (2020) · Biomaterials Research · doi:10.1186/s40824-020-00191-6 · Cited by 54
Fitzgerald‐Hughes, D., Devocelle, M. C., & Humphreys, H. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00954.x · Cited by 54
Targeting a Uniquely Nonspecific Prenyl Synthase with Bisphosphonates to Combat Cryptosporidiosis
Artz, J. D., Dunford, J. E., Arrowood, M. J., Dong, A., Chruszcz, M., Kavanagh, K. L., Minor, W., Russell, R. G. G., Ebetino, F. H., Oppermann, U. C. T., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.017 · Cited by 47
Isoalantolactone protects against Staphylococcus aureus pneumonia
Qiu, J., Luo, M., Wang, J., Dong, J., Li, H., Leng, B., Zhang, Q., Dai, X., Zhang, Y., Niu, X., et al. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02397.x · Cited by 47
“Unfortunately, over the last 20 years, there has been a decline in the discovery of new antibiotics, creating a pressing need for the development of alternative therapies (Liu et al., 2008).”
BackgroundQin, X., Coku, A., Inoue, K., & Tian, L. (2011) · Planta · doi:10.1007/s00425-011-1442-8 · Cited by 48
“aureus dehydrosqualene synthase (Liu et al. 2008) Planta (2011) 234:737–748 739”
Unraveling the role of membrane microdomains during microbial infections
Bagam, P., Singh, D. P., Inda, M. E., & Batra, S. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9386-9 · Cited by 50
“Further, targeting lipid raft formation in bacteria using small molecules has also been shown to reduce their virulence by regulating diverse processes including exoprotease production, biofilm formation, and attachment (Kong et al. 2006; Liu et al. 2008).”
BackgroundLee, J., Kim, Y., Raorane, C. J., Ryu, S. Y., Shim, J., & Lee, J. (2019) · Biofouling · doi:10.1080/08927014.2019.1657418 · Cited by 49
“Whole blood killing assays were performed as previously described (Liu et al. 2008).”
MethodTerpen‐Biosynthese: Modularitätsregeln
Oldfield, E., & Lin, F. (2011) · Angewandte Chemie · doi:10.1002/ange.201103110 · Cited by 46
Self-citationVaish, M., Price‐Whelan, A., Robles, T. R., Liu, J., Jereen, A., Christie, S., Alonzo, F., Benson, M. A., Torres, V. J., & KRULWICH, T. A. (2017) · Journal of Bacteriology · doi:10.1128/jb.00611-17 · Cited by 50
“The increase in pigment is recognized as a stress response (38, 39).”
BackgroundYang, Y., Wang, H., Zhou, H., Hu, Z., Shang, W., Rao, Y., Peng, H., Zheng, Y., Hu, Q., Zhang, R., et al. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01998-19 · Cited by 46
“important virulence factor owing to its antioxidant property (22, 23).”
BackgroundBavisetty, S. C. B., Mishra, D. P., & Narayan, B. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.07.008 · Cited by 50
Critical Assessment of the Prospects of Quorum-Quenching Therapy for Staphylococcus aureus Infection
Otto, M. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044025 · Cited by 48
Painter, K. L., Hall, A., Ha, K. P., & Edwards, A. M. (2017) · Infection and Immunity · doi:10.1128/iai.00659-17 · Cited by 51
Chan, H., Feng, X., Ko, T., Huang, C.-H., Hu, Y., Zheng, Y., Bogue, S., Nakano, C., Hoshino, T., Zhang, L., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja413127v · Cited by 44
Self-citationLiu, C.-I., Jeng, W. Y., Chang, W.-J., Ko, T., & Wang, A. H. ‐. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351254 · Cited by 48
“aureus CrtM—Many SQS inhibitors that mimic either FPP or PSPP can also greatly diminish CrtM activity and staphyloxanthin biosynthesis (18, 23, 29, 30).”
BackgroundSelf-citationMüller, A., Grein, F., Otto, A., Gries, K., Orlov, D., Zarubaev, V., Girard, M., Sher, X., Shamova, O., Roemer, T., et al. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.12.002 · Cited by 48
The msaABCR Operon Regulates the Response to Oxidative Stress in Staphylococcus aureus
Pandey, S., Sahukhal, G. S., & Elasri, M. O. (2019) · Journal of Bacteriology · doi:10.1128/jb.00417-19 · Cited by 48
Simvastatin inhibits Candida albicans biofilm in vitro
Liu, G., Vellucci, V. F., Kyc, S., & Hostetter, M. K. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181bd5bf8 · Cited by 43
Self-citationFetzer, C., Korotkov, V. S., Thänert, R., Lee, K. M., Neuenschwander, M., von Kries, J. P., Medina, E., & Sieber, S. A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201708454 · Cited by 43
Wang, C., Kim, J.-H., & Kim, S.-W. (2014) · Marine Drugs · doi:10.3390/md12094810 · Cited by 43
“association with the membranes [30,31].”
Sakai, K., Koyama, N., Fukuda, T., Mori, Y., Onaka, H., & Tomoda, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.48 · Cited by 43
Pendini, N. R., Yap, M., Polyak, S. W., Cowieson, N. P., Abell, A. D., Booker, G. W., Wallace, J. C., Wilce, J. A., & Wilce, M. C. J. (2013) · Protein Science · doi:10.1002/pro.2262 · Cited by 44
“For example, pathways required for virulence, such as biotin metabolism, provide an untapped source of potential new targets.(4,22,23) We have recently provided the first data to demonstrate it is possible to selectively inhibit SaBPL over both EcBPL and their human counterpart, holocarboxylase synthetase (HCS).”
BackgroundJitender Dev, G., Poornachandra, Y., Kuchukulla, R. R., Kumar, R., Ravikumar, N., Swaroop, D. K., Ranjithreddy, P., Kumar, G. S., Nanubolu, J. B., Kumar, C. G., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.052 · Cited by 41
Ahrazem, O., Diretto, G., Picazo, J. A., Fiore, A., Rubio‐Moraga, Á., Rial, C., Varela, R. M., Macías, F. A., Castillo, R., Romano, E., et al. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00249 · Cited by 48
Host-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus
Bravo-Santano, N., Stölting, H., Cooper, F., Bileckaja, N., Majstorović, A., Ihle, N., Mateos, L. M., Calle, Y., Behrends, V., & Letek, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41260-8 · Cited by 45
Wencewicz, T. A., Yang, B., Rudloff, J. R., Oliver, A. G., & Miller, M. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200794r · Cited by 40
Liu, Y.-L., Lindert, S., Zhu, W., Wang, K., McCammon, J. A., & Oldfield, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409061111 · Cited by 41
“FPP then is used in a wide range of reactions including the formation of geranylgeranyl diphosphate (GGPP) (1), squalene (involved in cholesterol and ergosterol biosynthesis), dehydrosqualene (used in formation of the Staphylococcus aureus virulence factor staphyloxanthin) (2), undecaprenyl diphosphate (used in bacter…”
Self-citationStaphylococcus aureus infections in children
Cassat, J. E., & Thomsen, I. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000752 · Cited by 42
Askoura, M., Yousef, N. E., Mansour, B., & Yehia, F. A. A. (2022) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-022-00513-7 · Cited by 44
Construction of carotenoid biosynthetic pathways using squalene synthase
Furubayashi, M., Li, L., Katabami, A., Saito, K., & Umeno, D. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.12.003 · Cited by 38
Pinto, H. B., Brust, F. R., Macêdo, A. J., & Trentin, D. D. S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104571 · Cited by 41
Mitsunaga, M., Ito, K., Nishimura, T., Miyata, H., Miyakawa, K., Morita, T., Ryo, A., Kobayashi, H., Mizunoe, Y., & Iwase, T. (2022) · Communications Biology · doi:10.1038/s42003-022-03586-4 · Cited by 39
Liu, H., Shang, W., Hu, Z., Zheng, Y., Yuan, J., Hu, Q., Peng, H., Cai, X., Tan, L., Li, S., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0078-1 · Cited by 36
Dong, P., Jusuf, S., Hui, J., Zhan, Y., Zhu, Y., Liu, G. Y., & Cheng, J. (2022) · JCI Insight · doi:10.1172/jci.insight.153079 · Cited by 41
“aureus functional membrane domains (25, 26), makes this pathogen vulnerable to low-concentration H2O2 (16).”
BackgroundSelf-citationSirtuins as emerging anti-parasitic targets
Zheng, W. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.11.014 · Cited by 44
Structure and Function of a “Head‐to‐Middle” Prenyltransferase: Lavandulyl Diphosphate Synthase
Liu, M., Chen, C., Chen, L., Xiao, X., Zheng, Y., Huang, J., Liu, W., Ko, T., Cheng, Y., Feng, X., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201600656 · Cited by 35
Self-citationDrug repurposing for antivirulence therapy against opportunistic bacterial pathogens
Rampioni, G., Visca, P., Leoni, L., & Imperi, F. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20160018 · Cited by 36
Staphylococcus aureus: setting its sights on the human innate immune system
Buchan, K. D., Foster, S. J., & Renshaw, S. A. (2019) · Microbiology · doi:10.1099/mic.0.000759 · Cited by 43
Ranganathan, N., Johnson, R., & Edwards, A. M. (2020) · Microbiology · doi:10.1099/mic.0.000983 · Cited by 39
“A larger relative increase in survival (3.7- fold) was seen for MJH502 incubated in blood containing DPI, confirming that the oxidative burst was required for most of the killing of S. aureus wild- type and MJH502 strains (Fig.”
BackgroundInfluential
Metadata
- Authors
- Liu, C.-I., Liu, G. Y., Song, Y., Yin, F., Hensler, M. E., Jeng, W.-Y., Nizet, V., Wang, A. H.-J., & Oldfield, E.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Liu, Chia-I
- Liu, George Y.
- Song, Yongcheng
- Nizet, Victor
- Wang, Andrew H.-J.
- Oldfield, Eric
- Venue
- Science
- Published
- 2008-03-07
- Volume
- 319
- Issue
- 5868
- Pages
- 1391-1394
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2747771
- OpenAlex
- W1986930831
- Cited by
- 490
- References
- 16
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 34 · 2023: 26 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 31 · 2018: 28 · 2017: 40 · 2016: 23 · 2015: 17 · 2014: 32 · 2013: 26 · 2012: 33
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM065307, GM073216, R01GM073216, GM65307)
- National Institute of Allergy and Infectious Diseases (AI07482)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 051796, R01HD051796)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Metabolism and Applications
- Keywords
- Staphylococcus aureus, cholesterol synthesis inhibition, CRTM, squalene synthase inhibitors, methicillin-resistant Staphylococcus aureus, bacterial virulence, reactive oxygen species resistance, crystal structure
- MeSH terms
- Amino Acid Sequence, Animals, Anti-Bacterial Agents, Bacterial Proteins, Cell Line, Cholesterol, Enzyme Inhibitors, Humans, Molecular Sequence Data, Organothiophosphorus Compounds, Polyisoprenyl Phosphates, Sesquiterpenes, Farnesyl-Diphosphate Farnesyltransferase, Staphylococcal Infections, Staphylococcus aureus, Virulence, Protein Structure, Secondary, Crystallography, X-Ray, Xanthophylls, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.